Previous study found Rg3 could modulate pancreatic cancer cell lines survival via phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway [14], which play a critical role in many hematological malignancies. The gene discussed is MTOR; the disease is familial pancreatic carcinoma.